Implementing Hepatitis C treatment among HIV/HCV coinfected             INTERIM GUIDANCE FOR CONTINUING HIV PROGRAM SERVICE DELIVERY DURING COVID-19 PANDEMIC             National Integrated Biological and Behavioral Surveillance (IBBS) Survey among PWID            

FHI 360 hands over 135,000 Determine test kits (Determine) to NCASC

A total of 135,000 Determine HIV test kits, which was received from Abbott PMTCT Donation Program by FHI 360, has been handed over to NCASC.   

In a formal hand over program, organized at NCASC on 24 Sept 2013, Mr. Satish Raj Pandey, Country Director, FHI 360 SSP, handed over the test kits to Dr. Naresh Pratap KC, Director, NCASC. 

Abbott is a global health care company dedicated to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutrition devices and diagnostics, and has been providing Determine test kits to NCASC through DRI PMTCT Donation Program each year since 2009. SSP/FHI 360 coordinated and communicated with DRI to resupply the test kits on 17 November 2012.  

“I hope this test kit support will really be valuable in order to scale up and increase the access of HIV testing services to people all over Nepal particularly to the needy communities and hence I would like to thank Abbott and FHI 360 for this support” said Dr. KC Director, NCASC, while taking over the test kits. 

Mr. Satish Pandey, Country Director, SSP/FHI 360 committed his continued support to NCASC in HIV prevention and control in Nepal.